Jonathan JK Stoltman, PhD is Director of the Opioid Policy Institute. They have been an addiction scientist since 2013. Their work has appeared in leading academic journals and in the media.
Digital Health
Our recent invited commentary about surveillance capitalism in addiction digital health. We make bold calls for corrective action and leadership on this issue. Read more here: Privacy and Digital Health: Causes for Concern and a Way... : Journal of Addiction MedicineAn abstract is unavailable.LWW[email protected]💡We're always
Digital Health
It's been 1,384 days and still no health breach notifications from 22 companies blatantly violating people's health privacy rights.
Policy
Support Whistleblower Aid, EFF, 404 Media, Wired, and Techdirt
Policy
Let's get these bills out of committee on December 5th
In the News
Elegy: The Many Myths of JD Vance (Ep. 4: Cultural Heroin) Great to chat with Madeline Fening about opioid addiction and the importance of politicians using their platform to inform the public about solutions not dehumanizing and demagoguing. 🔊30min listen
In the News
Slow-moving Michigan AG spurred to action by Opioid Policy Institute complaint.
In the News
Priorities for Opioid Settlement Money: Spend Now vs. Invest for Future 3 minutes📽️ “That’s not to say that prevention isn't important, but we also know prevention is a real long game,” Stoltman said. “If you think about it as like the building is on fire, the first
In the News
Michigan's continued moves to obfuscate opioid settlement spending.
Digital Health
Wired (6 Sept 2024)🔒 This is bad. +120,000 files +1.7 million activity logs 5.3 terabytes of data Intake files Audio of sessions Video of sessions Drug tests Therapy notes all were exposed on an unsecured database. This is a privacy and security disaster.
In the News
Exposing bad opioid policy stances in Michigan's 2024 US Senate candidate
In the News
Michigan could see over $100 million in opioid settlement money this year "Some of the most important spending has been increasing naloxone distribution; that's the overdose reversal medication," said Jonathan Soltman, the director of the Opioid Policy Institute. "Trying to target high-risk communities and make
Opioid Settlement Money
It's time to change how the opioid settlement money is tracked in Michigan.